SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-052485
Filing Date
2024-05-03
Accepted
2024-05-03 07:34:20
Documents
90
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flgt-20240331.htm   iXBRL 10-Q 2123830
2 EX-31.1 flgt-ex31_1.htm EX-31.1 14173
3 EX-31.2 flgt-ex31_2.htm EX-31.2 14246
4 EX-32.1 flgt-ex32_1.htm EX-32.1 16364
  Complete submission text file 0000950170-24-052485.txt   11103237

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT flgt-20240331.xsd EX-101.SCH 1618212
94 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20240331_htm.xml XML 2367834
Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37894 | Film No.: 24910801
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)